Skip to main content
. Author manuscript; available in PMC: 2007 Mar 19.
Published in final edited form as: Immunity. 2007 Jan 11;26(1):105–116. doi: 10.1016/j.immuni.2006.12.004

Figure 1.

Figure 1

Circulating linhCD25+ precursors. (A) Lineage depleted BM and blood cells from hCD25 transgenic and non-transgenic mice were stained for lineage markers, hCD25, c-kit and B220. The lower panels show the expression of c-kit and B220 of electronically gated linhCD25+ cells. Numbers in FACS plots indicate percentages of cells within gates or quadrants. (B) Expression of pre-TCRα in circulating linhCD25+ cells. RT-PCR was performed on 250 CTP cells. The same amount of cDNA from hCD25+ DN3 cells and DN3 cells from Ptcra−/− mice was used as positive and negative controls, respectively. One representative out of 2 independent experiments is shown. (C) Expression of surface markers on different linhCD25+ populations. BM CLP-1 (linhCD25+ckit+B220) and CLP-2 (linhCD25+c-kit−/loB220+) cells, blood linhCD25+B220+ cells (“B220+”) and CTP (linhCD25+B220) and thymic hCD25+ DN1 (linCD25CD44hihCD25+) cells were stained for c-kit, IL-7Rα, Flt3, Sca-1, CD44 and Thy-1.1. Histograms show expression levels of the respective surface markers (blue histograms) or unstained controls (red histograms) of electronically gated populations as indicated above. One representative out of 2 independent experiments is shown.

HHS Vulnerability Disclosure